AIM: Review of clinical and cognitive predictors of psychosocial functioning during the euthymic period in patients with bipolar disorder type II (BD II) was aimed in this paper. Psychosocial functioning status, clinical and cognitive predictors of psychosocial functioning and assessment of psychosocial functioning during the euthymic period in patients with BD-II were discussed. METHOD: Studies investigated psychosocial functioning and its clinical and cognitive predictors were reviewed. Studies conducted between 1990 and 2013 were scanned. RESULTS: It's been seen that there were limited studies investigating psychosocial functioning and predictors of psychosocial functioning. Findings from these limited studies indicated that patients with BD-II experienced psychosocial disability as much as BD-I did. It was reported that subclinical depressive symptoms and cognitive impairment were the prominent predictors of psychosocial functioning during the euthymic periods in patients with BD-II. CONCLUSION: There are limited studies conducted in euthymic BD-II patients. There are various findings among the studies. Nevertheless, subclinical depressive symptoms and cognitive impairments are the prominent predictors of psychosocial functioning in euthymic BD-II patients. However, follow-up and cross-sectional studies are needed in this area.
AIM: Review of clinical and cognitive predictors of psychosocial functioning during the euthymic period in patients with bipolar disorder type II (BD II) was aimed in this paper. Psychosocial functioning status, clinical and cognitive predictors of psychosocial functioning and assessment of psychosocial functioning during the euthymic period in patients with BD-II were discussed. METHOD: Studies investigated psychosocial functioning and its clinical and cognitive predictors were reviewed. Studies conducted between 1990 and 2013 were scanned. RESULTS: It's been seen that there were limited studies investigating psychosocial functioning and predictors of psychosocial functioning. Findings from these limited studies indicated that patients with BD-II experienced psychosocial disability as much as BD-I did. It was reported that subclinical depressive symptoms and cognitive impairment were the prominent predictors of psychosocial functioning during the euthymic periods in patients with BD-II. CONCLUSION: There are limited studies conducted in euthymic BD-II patients. There are various findings among the studies. Nevertheless, subclinical depressive symptoms and cognitive impairments are the prominent predictors of psychosocial functioning in euthymic BD-II patients. However, follow-up and cross-sectional studies are needed in this area.